Maximum quantity allowed is 999
请选择数量
CAS RN: 19388-87-5 | 产品编码: T3980
Taurolidine

产品编码 | T3980 |
纯度/分析方法 | >98.0%(T) |
分子式/分子量 | C__7H__1__6N__4O__4S__2 = 284.35 |
外观与形状(20°C) | 固体 |
储存温度 | 冷藏 (0-10°C) |
储存在惰性气体下 | 存放于惰性气体之中 |
应避免的情况 | 光,空气,加热 |
包装和容器 | 250MG-Glass Bottle with Plastic Insert (查看图片) |
CAS RN | 19388-87-5 |
Reaxys-RN | 550774 |
PubChem物质ID | 468593050 |
MDL编号 | MFCD00865076 |
技术规格
Appearance | White to Light yellow powder to crystal |
Purity(Volumetric Analysis) | min. 98.0 % |
NMR | confirm to structure |
物性(参考值)
熔点 | 175 °C |
GHS
相关法规
RTECS# | XI2283800 |
运输信息
HS编码* | 2934.99-000 |
应用
Taurolidine: An Anti-Bacterial Agent with Anti-Tumor Effects
Taurolidine consists of two taurinamide rings derived from the aminosulfoacid taurine. Taurolidine was first developed as an anti-bacterial agent against a wide range of gram-positive and gram-negative bacteria, mycobacteria and some fungi.1,2) In clinical, taurolidine is mainly used in the treatment of peritonitis. In the 2000s, it has also been reported that taurolidine shows anti-tumor effects, such as anti-angiogenetic and apoptosis-inducing effects.3,4) (The product is for research purpose only.)
References
- 1) Taurolin, a new chemotherapeutic agent
- 2) Taurolidine Antiadhesive Properties on Interaction with E. coli; Its Transformation in Biological Environment and Interaction with Bacteria Cell Wall
- 3) Taurolidine-a new drug with anti-tumor and anti-angiogenic effects (a review)
- 4) The evolving role of taurolidine in cancer therapy (a review)
产品文档 (部分产品的分析图谱无法提供,敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助,请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注:该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉,您搜索的分析图谱无法提供。